Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Breast 4Genitourinary 1

Conditions

Breast Neoplasms 2Breast Cancer Patients 2Prostatic Neoplasms 1Chronic Pain 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Polymorphism, Single Nucleotide × Clear all
NCT05507034 2023-12-27

sCANsens

Universiteit Antwerpen

Unknown
150 enrolled
Breast

Breast Neoplasms, Chronic Pain

NCT01739062 2023-12-04

ProCaRis

University of Aarhus

Phase NA Active not recruiting
5,000 enrolled
Genitourinary

Prostatic Neoplasms

NCT04654195 2020-12-04

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Damanhour University

Unknown
100 enrolled
Breast

Breast Cancer Patients

NCT04581967 2020-10-09

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Damanhour University

Unknown
100 enrolled
Breast

Breast Cancer Patients

NCT00283608 2011-05-16

Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer

Mayo Clinic

Completed
1,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡